Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Aug 6th, 5:36 AM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | 25.15 - 31.77 |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology ( https://ibn.fm/6xni4 ). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S. and international patents, with additional applications pending.
Via Investor Brand Network · August 5, 2025
Study Finds That Inflammation Markers in Diabetics Influence Depression Treatment Outcomes
On average, diabetics tend to suffer from depression at higher rates than is seen in the general population. A new study conducted by a team at the German Diabetes Center and other institutions in Germany has found that the markers of chronic inflammation influence how successful the treatments provided for depression will be for patients living with diabetes.
Via Investor Brand Network · August 5, 2025
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and MS, announced that its management will present at the Canaccord 45th Annual Growth Conference and participate in one-on-one investor meetings.
Via Investor Brand Network · August 5, 2025
BioMedNewsBreaks — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the 50% of women with dense breast tissue.
Via Investor Brand Network · August 5, 2025
Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone
Obtaining approval from the U.S. Food and Drug Administration (“FDA”) is a monumental achievement for any biopharmaceutical company, serving as a critical validation of a drug’s safety and efficacy. This rigorous process is a cornerstone of public health, ensuring that only treatments proven to be beneficial and with acceptable risks reach patients. Recognizing the immense value this milestone represents, Nutriband (NASDAQ: NTRB) recently underscored its commitment to this pathway by announcing a 25% preferred stock dividend as the company targets filing for FDA approval for its lead product, AVERSA(TM) Fentanyl ( https://ibn.fm/8FRUA ).
Via Investor Brand Network · August 5, 2025
The global automotive industry is currently navigating a period of profound transformation, marked by groundbreaking strategic shifts, evolving market dynamics, and significant leadership changes. Recent developments, including a colossal new pay package for Tesla (NASDAQ: TSLA) CEO Elon Musk tied to the company's ambitious robotaxi and humanoid robot ventures, the
Via MarketMinute · August 4, 2025
Irvine, Calif. – Modern Elite Transportation, a trusted name in executive ground travel since 2010, has launched a redesigned website that reflects its growing role as a mobility partner to professionals, event organizers, and institutions requiring precision and discretion. With operations centered in Southern California and now expanding globally, the company continues to embody its mission: Moving Those Who Move the World .
Via GetFeatured · August 4, 2025
Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment
Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams could rely on to predict which patients having glioblastoma stand higher chances of benefiting from bevacizumab, a cancer drug.
Via Investor Brand Network · August 1, 2025
BMW Group commenced its San Luis Potosí plant expansion in Mexico, with Jilian Group serving as the lead electromechanical engineering contractor. The expansion project in Mexico recently held its groundbreaking ceremony. Senior executives from Jilian joined BMW Mexico’s management team in witnessing this strategic milestone.
Via Binary News Network · August 1, 2025
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether they could be exhibiting signs of Parkinson’s . The research explaining this speech tool appeared in the npj Parkinson’s Disease journal.
Via Investor Brand Network · July 31, 2025
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will host the call, followed by a question-and-answer session.
Via Investor Brand Network · July 30, 2025
QuantumScape Corporation (NYSE:QS), a leading developer of solid-state lithium-metal batteries for electric vehicles, saw its shares drop sharply following its latest earnings announcement. The decline reflects growing investor concern over the company’s financial performance, delayed commercialization roadmap, and heightened competition in the solid-state battery space.
Post-Earnings Stock Reaction
Via MarketMinute · July 29, 2025
Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’
Izotropic (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of breast cancer. Focused exclusively on this clinical area, Izotropic is developing purpose-built technologies designed to address persistent limitations in conventional breast imaging. Through innovation in both device architecture and image acquisition, the company aims to enhance diagnostic confidence while improving patient experience.
Via Investor Brand Network · July 29, 2025
Study Discovers That Autoantibodies in Patients Could Boost Cancer Immunotherapy
For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients and not others. This challenge has made it difficult for these immunotherapies to be widely used since it isn’t easy to predict who will benefit and yet the treatments are currently very expensive .
Via Investor Brand Network · July 29, 2025
The move comes as Harley braces for a challenging year, with mounting tariff costs, a pending CEO transition, and efforts to attract younger riders with more affordable models.
Via Stocktwits · July 28, 2025
Las Vegas, Nevada - SmartTOP manufacturer Mods4cars has announced a permanent price reduction for its SmartTOP convertible top control module for Volkswagen Beetle Convertible. The retrofittable SmartTOP module is now available for 149.00 Euros plus tax. “We’re pleased that even more VW Beetle drivers can now enjoy the benefits of our feature-rich upgrade,” says PR spokesperson Sven Tornow.
Via Get News · July 28, 2025
Libertyville, IL () July 28, 2025 -- Expert BMW maintenance at Auto Lab Libertyville redefines luxury vehicle care for local drivers
Via Prodigy · July 28, 2025
BioMedNewsBreaks — HealthLynked Corp. (OTCQB: HLYK) Launches Enterprise Healthcare Solutions Website and Upgrades Provider Directory
HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com , and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in the healthcare ecosystem and its commitment to scalable solutions that improve outcomes and reduce costs.
Via Investor Brand Network · July 28, 2025
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform
Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds the potential to be the world’s first opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. In addition, Nutriband is advancing AVERSA Buprenorphine, which upon approval is projected to achieve peak U.S. sales between $70 and $130 million. Both candidates benefit from Nutriband’s scalable platform, and the technology is on track for global patent protection.
Via Investor Brand Network · July 25, 2025
Survey Finds That US Healthcare Workers Worry About Personal Safety
According to a new survey, approximately 60% of workers in the U.S. healthcare sector are concerned about their personal safety while at work and these concerns are prompting many to consider quitting their positions. This situation is concerning because the healthcare industry is already facing worker shortages and those who want to leave could worsen matters.
Via Investor Brand Network · July 25, 2025
Oral mucositis, a debilitating side effect of cancer therapy with no FDA-approved treatment, continues to wreak havoc on patients undergoing cancer care, prompting an urgent need for effective interventions. Soligenix (NASDAQ: SNGX) is stepping forward with SGX942, a novel therapeutic aimed at alleviating this condition, with promising phase 3 data showing substantial improvements in the duration and severity of mucositis in head and neck cancer patients .
Via Investor Brand Network · July 24, 2025
Global Vaccination Goals at Risk as 14 Million Kids Miss Crucial Shots
Latest UN data indicates that at least 14 million kids didn’t receive life-saving shots of vaccines against tetanus, whooping cough and diphtheria in 2024. This threatens the attainment of global vaccination goals.
Via Investor Brand Network · July 24, 2025
Trump announces 15% tariffs on Japan imports, causing European automakers' shares to rally. Uncertainty remains on EU deal.
Via Benzinga · July 23, 2025
Melbourne riders now have a dependable way to sell their damaged motorcycles and find affordable used parts, thanks to Motorbike Wreckers Melbourne. Specialising in road, enduro, and dirt bikes, the company offers fast cash deals, same-day pickup, and access to an extensive inventory of tested motorcycle parts. Customers across Victoria and wider Australia benefit from a smooth, stress-free experience whether buying or selling.
Via Get News · July 22, 2025